Dihydropyrimidine Dehydrogenase Testing prior to Treatment with 5-Fluorouracil, Capecitabine, and Tegafur: A Consensus Paper.

Wörmann B, Bokemeyer C, Burmeister T, Köhne CH, Schwab M, Arnold D, Blohmer JU, Borner M, Brucker S, Cascorbi I, Decker T, de Wit M, Dietz A, Einsele H, Eisterer W, Folprecht G, Hilbe W, Hoffmann J, Knauf W, Kunzmann V, Largiadèr CR, Lorenzen S, Lüftner D, Moehler M, Nöthen MM, Pox C, Reinacher-Schick A, Scharl A, Schlegelberger B, Seufferlein T, Sinn M, Stroth M, Tamm I, Trümper L, Wilhelm M, Wöll E, Hofheinz RD

Open source

DOI
10.1159/000510258
Published
2020
Container
Oncology research and treatment
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1159/000510258,
  title = {Dihydropyrimidine Dehydrogenase Testing prior to Treatment with 5-Fluorouracil, Capecitabine, and Tegafur: A Consensus Paper.},
  author = {Wörmann B and Bokemeyer C and Burmeister T and Köhne CH and Schwab M and Arnold D and Blohmer JU and Borner M and Brucker S and Cascorbi I and Decker T and de Wit M and Dietz A and Einsele H and Eisterer W and Folprecht G and Hilbe W and Hoffmann J and Knauf W and Kunzmann V and Largiadèr CR and Lorenzen S and Lüftner D and Moehler M and Nöthen MM and Pox C and Reinacher-Schick A and Scharl A and Schlegelberger B and Seufferlein T and Sinn M and Stroth M and Tamm I and Trümper L and Wilhelm M and Wöll E and Hofheinz RD},
  year = {2020},
  journal = {Oncology research and treatment},
  doi = {10.1159/000510258},
  url = {https://doi.org/10.1159/000510258}
}

RIS

TY  - JOUR
TI  - Dihydropyrimidine Dehydrogenase Testing prior to Treatment with 5-Fluorouracil, Capecitabine, and Tegafur: A Consensus Paper.
AU  - Wörmann B
AU  - Bokemeyer C
AU  - Burmeister T
AU  - Köhne CH
AU  - Schwab M
AU  - Arnold D
AU  - Blohmer JU
AU  - Borner M
AU  - Brucker S
AU  - Cascorbi I
AU  - Decker T
AU  - de Wit M
AU  - Dietz A
AU  - Einsele H
AU  - Eisterer W
AU  - Folprecht G
AU  - Hilbe W
AU  - Hoffmann J
AU  - Knauf W
AU  - Kunzmann V
AU  - Largiadèr CR
AU  - Lorenzen S
AU  - Lüftner D
AU  - Moehler M
AU  - Nöthen MM
AU  - Pox C
AU  - Reinacher-Schick A
AU  - Scharl A
AU  - Schlegelberger B
AU  - Seufferlein T
AU  - Sinn M
AU  - Stroth M
AU  - Tamm I
AU  - Trümper L
AU  - Wilhelm M
AU  - Wöll E
AU  - Hofheinz RD
PY  - 2020
JO  - Oncology research and treatment
DO  - 10.1159/000510258
UR  - https://doi.org/10.1159/000510258
ER  - 

APA

B, W., C, B., T, B., CH, K., M, S., D, A., JU, B., M, B., S, B., I, C., T, D., M, D. W., A, D., H, E., W, E., G, F., W, H., J, H., W, K., V, K., CR, L., S, L., D, L., M, M., MM, N., C, P., A, R., A, S., B, S., T, S., M, S., M, S., I, T., L, T., M, W., E, W., & RD, H. (2020). Dihydropyrimidine Dehydrogenase Testing prior to Treatment with 5-Fluorouracil, Capecitabine, and Tegafur: A Consensus Paper.. Oncology research and treatment. https://doi.org/10.1159/000510258

Source records